EARNINGS SEASON
Cronos announced it would delay its Q4 and full-year reporting, but did not explain why, except to say it had suffered a delay in finishing its financial statements. CBC Business, The Star
- Cronos's largest shareholder is Marlboro parent Altria, which paid $2.4B for 45% of Cronos stock. Cronos is now worth . . .
Log in or become a WeedWeek Member to read this article.
